Canaccord|BGF did a research note back in Feb 2012.
CMG has reported a strong 1H12 result up 55% in revenue to $771.4m and up 50% up in EBIDA to $19.9m
· 1H12 EPS was up 40%, with the RHD acquisition benefits delivering, and also organic revenue growth robust (up 11%)
· The business performance was solid across all divisions
· CMG announced the acquisition of AHS services, which is 14.4% EPS accretive on our FY13 forecasts
· Management remains positive, with a strong forward pipeline, and 36 contract wins in the 1H (CMG is winning market share)
We have upgraded our FY13 EPS by 19.0%, with favourable amortisation adjustments.
We consequently increased our DCF valuation to $0.60 (from $0.55), and reiterate our BUY recommendation.
CMG is trading on a FY12 PER of 7.8x and FY13 PER of 6.2x which represents an excessive discount, relative to our forecast EPS growth of 26.7% in FY12, and 25.3% (FY13)
moelis stockbroker, page-2
Add CMG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.020(12.1%) |
Mkt cap ! $10.88M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 18.5¢ | 18.5¢ | $1.523K | 8.233K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49999 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 12310 | 1 |
View Market Depth
| Last trade - 13.14pm 30/08/2024 (20 minute delay) ? |
| CMG (ASX) Chart |